pubmed-article:10476873 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C0031740 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C0220781 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C1883254 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C1149369 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C1510827 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
pubmed-article:10476873 | lifeskim:mentions | umls-concept:C0301869 | lld:lifeskim |
pubmed-article:10476873 | pubmed:issue | 16 | lld:pubmed |
pubmed-article:10476873 | pubmed:dateCreated | 1999-10-14 | lld:pubmed |
pubmed-article:10476873 | pubmed:abstractText | A tetraphenylporphyrin-C11-beta-estradiol conjugate has been synthesized. Competitive binding assay of the conjugate with estrogen receptor (ER)-ligand-binding domain showed that the conjugate binds specifically to the protein with high affinity. Potential use of this conjugate to selectively deliver cytotoxic porphyrins to ER-positive cells in various carcinomas is discussed. | lld:pubmed |
pubmed-article:10476873 | pubmed:language | eng | lld:pubmed |
pubmed-article:10476873 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10476873 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:10476873 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10476873 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10476873 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10476873 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10476873 | pubmed:month | Aug | lld:pubmed |
pubmed-article:10476873 | pubmed:issn | 0960-894X | lld:pubmed |
pubmed-article:10476873 | pubmed:author | pubmed-author:RazSS | lld:pubmed |
pubmed-article:10476873 | pubmed:author | pubmed-author:HansonR NRN | lld:pubmed |
pubmed-article:10476873 | pubmed:author | pubmed-author:JamesD ADA | lld:pubmed |
pubmed-article:10476873 | pubmed:author | pubmed-author:SwamyNN | lld:pubmed |
pubmed-article:10476873 | pubmed:author | pubmed-author:PauCC | lld:pubmed |
pubmed-article:10476873 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10476873 | pubmed:day | 16 | lld:pubmed |
pubmed-article:10476873 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:10476873 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10476873 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10476873 | pubmed:pagination | 2379-84 | lld:pubmed |
pubmed-article:10476873 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:meshHeading | pubmed-meshheading:10476873... | lld:pubmed |
pubmed-article:10476873 | pubmed:year | 1999 | lld:pubmed |
pubmed-article:10476873 | pubmed:articleTitle | Synthesis and estrogen receptor binding affinity of a porphyrin-estradiol conjugate for targeted photodynamic therapy of cancer. | lld:pubmed |
pubmed-article:10476873 | pubmed:affiliation | Department of Medicine, Boston University School of Medicine, MA 02118, USA. | lld:pubmed |
pubmed-article:10476873 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | http://linkedlifedata.com/r... | pubmed-article:10476873 | lld:chembl |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10476873 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10476873 | lld:pubmed |